RecruitingPhase not listedNCT06297291
Global Paradise System US Post Approval Study
Sponsor: ReCor Medical, Inc.
Salt Lake City, UT · +45 more sites
Hypertension clinical trials in Salt Lake City, UT
12 recruiting hypertension studies with a site in Salt Lake City, UT.
RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Bountiful, UT · Layton, UT · +270 more sites
RecruitingPhase 3NCT07179380
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Sponsor: Insmed Incorporated
Salt Lake City, UT · +18 more sites
RecruitingNot applicableNCT06911632
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Sponsor: Tempus AI
Salt Lake City, UT · +39 more sites
RecruitingPhase 1NCT02966665
: Vascular Function in Health and Disease
Sponsor: D. Walter Wray
Salt Lake City, UT
RecruitingNot applicableNCT06559891
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Sponsor: SoniVie Inc.
Salt Lake City, UT · +33 more sites
RecruitingNot applicableNCT04553523
Hydrus® Microstent New Enrollment Post-Approval Study
Sponsor: Alcon Research
Salt Lake City, UT · +21 more sites
RecruitingPhase not listedNCT06388421
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Sponsor: United Therapeutics
Murray, UT · Salt Lake City, UT · +68 more sites
RecruitingPhase not listedNCT04278404
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Sponsor: Duke University
Salt Lake City, UT · +49 more sites
RecruitingPhase 1 / Phase 2NCT06649110
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Sponsor: Novartis Pharmaceuticals
Salt Lake City, UT · +19 more sites
RecruitingPhase not listedNCT06129240
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Sponsor: Liquidia Technologies, Inc.
Salt Lake City, UT · +22 more sites
RecruitingNot applicableNCT05826925
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
Sponsor: University of Utah
Salt Lake City, UT
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.